Showing results (1-10 of 1,634) with videos related to
Sort By:
Pageof 164
Alimentary Pharmacology & Therapeutics|April 28, 2017
Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trialX Roblin, G Boschetti, N Williet, et al.Journal of Crohn'S & Colitis|January 16, 2015
Efficacy of sustained combination therapy for at least 6 months with thiopurines and infliximab in patients with ulcerative colitis in clinical remission: a retrospective multicenter French experienceJ Filippi, D Laharie, C Michiels, et al.BMC Gastroenterology|June 21, 2017
Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literatureC Venturin, S Nancey, P Danion, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 8, 2025
Impact of immediate drug optimization of ustekinumab on medium term targets in Crohn's disease: results from the multicentre retrospective real-life study MUSTM Hupé, A Abdelmoula, T Chateau, et al.Alimentary Pharmacology & Therapeutics|February 1, 2018
Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational studyW Yacoub, N Williet, L Pouillon, et al.Alimentary Pharmacology & Therapeutics|March 26, 2013
Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experienceD Laharie, J Filippi, X Roblin, et al.United European Gastroenterology Journal|March 25, 2026
Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel DiseaseX Roblin, S Nancey, K Papamichael, et al.Journal of Crohn'S & Colitis|April 22, 2015
Association of Anti-glycan Antibodies and Inflammatory Bowel Disease CourseS Paul, G Boschetti, M Rinaudo-Gaujous, et al.Alimentary Pharmacology & Therapeutics|September 5, 2013
Review article: biosimilars are the next generation of drugs for liver and gastrointestinal diseasesM Rinaudo-Gaujous, S Paul, E D Tedesco, et al.Gastroenterologie Clinique Et Biologique|January 1, 1996
[Laxative effect and tolerance of lactulose administrated in one or two intakes in the treatment of chronic idiopathic constipation. Groupe d'Investigateurs O'Ile-de-France (GIIF)]I Sobhani, M Sansarricq, B FlouriePageof 164